ORAI1 and cancer: Regarding the STIM1/Orai1-mediated SOCE, further studies aiming at developing potent and selective inhibitors that target cancer cell-specific microtubule-dependent STIM1 trafficking mechanism on SOCE activation will facilitate better therapeutic approaches.